Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Viviana Giannuzzi, PhD, Mariagrazia Felisi, PhD, Hugo Devlieger, Aurelio Maggio, MD, George Papanikolaou, MD PhD, Giorgio Reggiardo, Bianca Tempesta, PhD, Fernando Tricta, MD, Donato Bonifazi

Blood (2019) 134 (Supplement_1): 4820.

https://doi.org/10.1182/blood-2019-124689

Published: 2019

Journal Articles

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Livingstone Gayus Dogara, MBBS, FMCPath, Joseph Ogirima Ovosi, MBBS, MSc, FMCP (Clinical Pharmacology), Caleb Mohammed, MBBS, FWACS, Bilkisu Farouk, MBBS, FWACS, Ziphozonke Mafika, MBBCH, MMed, FCPath, Johnny Mahlangu

Blood (2018) 132 (Supplement 1): 5056.

https://doi.org/10.1182/blood-2018-99-114865

Published: 2018

Journal Articles

Epidemiological Data from the Algerian Multiple Myeloma Registry (AMMR) over 2 Years (June 2014-June 2016): Report of the Algerian Multiple Myeloma Study Group (GETMA)

Blood (2017) 130 (Supplement 1): 5385.

https://doi.org/10.1182/blood.V130.Suppl_1.5385.5385

Published: 2017

Journal Articles

Descriptive Study of Diffuse Large B Cell Lymphoma in Algeria and Tunisia over a Period of 5 Years

Blood (2016) 128 (22): 5412.

https://doi.org/10.1182/blood.V128.22.5412.5412

Published: 2016

Journal Articles

Depth of Response to ≥VGPR at Completion of Induction Influences Outcome Post ASCT, on Behalf of the Tunisian Myeloma Study Group

Blood (2016) 128 (22): 5827.

https://doi.org/10.1182/blood.V128.22.5827.5827

Published: 2016

Journal Articles

Epidemiological Approach of Chronic Myeloid Leukemia. Algerian-Tunisian Study

Blood (2016) 128 (22): 5440.

https://doi.org/10.1182/blood.V128.22.5440.5440

Published: 2016

Journal Articles

Safety of Subcutaneous Administration of Rituximab during the First-Line Treatment of Patients with Non-Hodgkin Lymphoma: The MabRella Study

Carlos Panizo, Mohamed Amine Bekadja, Balkis Meddeb, Maria Rigoroso Mendoza, Matt Truman, Rodney Smith, Claudia Baratè

Blood (2016) 128 (22): 2971.

https://doi.org/10.1182/blood.V128.22.2971.2971

Published: 2016

Journal Articles

Prospective, Multinational/Regional, Non-Interventional Study to Assess Treatment Practices in Anemia Patients Prone to Iron Overload: Results from the 3-Year Transfusional Hemosiderosis Registry (TORS)

Noppadol Siritanaratkul, Jong Wook Lee, Jun Ma, Mustafa Pehlivan, Elena Volodicheva, Qian Jiang, Fatiha Grifi, Bor-Sheng Ko, Raymond Wong, Vernon Louw, Abderrahim Khelif, Ali El-Ali, Jackie Han, Alfonso Losco, Osman Ilhan

Blood (2015) 126 (23): 2152.

https://doi.org/10.1182/blood.V126.23.2152.2152

Published: 2015

Journal Articles

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Timothy P. Hughes, MD, Eduardo Ciliao Munhoz, MD, Alaa Elhaddad, MD PhD, Ong Tee Chuan, MD, Kudrat Abdulkadyrov, MD, Jake Shortt, MD, Hang Quach, MD FRACP, FRCPA, MBBS, Carolina Pavlovsky, MD, Vernon J. Louw, MBChB, M.MD FCP(SA), PhDHPE), Luis Meillon, MD, Lee-Yung Shih, MD Professor, Anna G. Turkina, MD PhD, Jonathan Hwang, PharmD, MBA, Prasanna Kumar Nidamarthy, Darshan Dalal, MD PhD MPH, Jeffrey H. Lipton, PhD MD

Blood (2014) 124 (21): 4542.

https://doi.org/10.1182/blood.V124.21.4542.4542

Published: 2014

Journal Articles

Chronic Myeloid Leukemia Patients In Tunisia: Epidemiology and Outcome In The Imatinib Era (A Multicentric Experience)

Raihane Ben Lakhal, Hela Ghedira, Hatem Bellaaj, Yosra Ben Youssef, Samia Menif, Zeineb Manai, Manel Bedoui, Amel Lakhal, Balkis Meddeb

Blood (2013) 122 (21): 4037.

https://doi.org/10.1182/blood.V122.21.4037.4037

Published: 2013

Journal Articles

Hypercoagulability Linked to Breast Cancer Depends On the Stage and the Duration of the Tumor Evolution

Mourad Chaari, Grigoris T Gerotziafas, Lilia Ghorbal, Vassiliki Galea, Ines Ayadi, Patrick Van Dreden, Mariette Adam, Racem Bouzguenda, Mounir Frikha, Jamel Daoud, Choumous Kallel, Barry J Woodhams, Ismail Elalamy

Blood (2012) 120 (21): 3396.

https://doi.org/10.1182/blood.V120.21.3396.3396

Published: 2012

Journal Articles

Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience

Hend Ben Neji, Yosr Ben Abdennebi, Lamia Aissaoui, Ramzi Jeddi, Mohamed Zarrouk, Ramzi Ben amor, Karima Kacem, Raihane Ben Lakhal, Zaher Belhadj Ali, Hela Ben Abid, Balkis Meddeb

Blood (2012) 120 (21): 4297.

https://doi.org/10.1182/blood.V120.21.4297.4297

Published: 2012

Journal Articles

Markers of Hypercoagulability in Breast Cancer: What Is Their Clinical Relevance?

Mourad Chaari, Grigoris T Gerotziafas, Ines Ayadi, Vassiliki Galea, Lilia Ghorbal, Patrick Van Dreden, Aurélie Rousseau, Racem Bouzguenda, Mounir Frikha, Jamel Daoud, Choumous Kallel, Barry J Woodhams, Ismail Elalamy

Blood (2012) 120 (21): 5133.

https://doi.org/10.1182/blood.V120.21.5133.5133

Published: 2012

Journal Articles

Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

Ramzi Jeddi, Hèla Ghédira, Hèla Stambouli, Ramzi Ben amor, Karima Kacem, MD, Yosr Ben Abdennebi, Mohamed Zarrouk, Hend Ben Neji, Raihane ben Lakhal, Lamia Aissaoui, Samia Menif, Emna Gouider, Hèla Ben Abid, Zaher Ben Hadjali, Pierre Fenaux, MD, PhD, Balkis Meddeb, MD

Blood (2011) 118 (21): 4271.

https://doi.org/10.1182/blood.V118.21.4271.4271

Published: 2011

Journal Articles

Human Platelet Alloantigens (HPA)1, HPA2 and HPA3 SNPs in Tunisian Sickle Cell Disease Patients

Adel Driss, PhD, MSc, BSc, Karima Kacem, MD, Nana Wilson, MPH, Jacqueline Hibbert, PhD, Tom Adamkiewicz, MD, MSCR, FRCP(C), Beatrice E Gee, MD, Balkis Meddeb, MD, Jonathan K Stiles, PhD

Blood (2011) 118 (21): 4852.

https://doi.org/10.1182/blood.V118.21.4852.4852

Published: 2011

Journal Articles

Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections.

Ramzi Jeddi, Hèla Ghédira, Ramzi ben Amor, Lamia Aissaoui, Karima Kacem, Walid Bouterâa, Yosr ben Abdennebi, Raihane ben Lakhal, Amel Turki, Hèla ben Abid, Zaher Belhadjali, Balkis Meddeb

Blood (2009) 114 (22): 4552.

https://doi.org/10.1182/blood.V114.22.4552.4552

Published: 2009

Journal Articles

Hodgkin Lymphoma (HL) in Tunisia Results of a 5 Year Prospective Multicenter Trial in 251 Pts

R. Ben Lakhal, S. Hdiji, M. A Laatiri, S. Ladeb, R. Jeddi, L. Aissaoui, R. Ben Amor, F. Msadek, H. Frikha, N. Toumi, J. Daoud, N. Bouaouina, Z. Belhadj Ali, H. Ben Abid, M. Frikha, M. Elloumi, A. Khelif, B. Meddeb, Pierre Fenaux, MD, PhD

Blood (2008) 112 (11): 2597.

https://doi.org/10.1182/blood.V112.11.2597.2597

Published: 2008

Journal Articles

Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.

Maria Cappellini, MD, Mohamed Bejaoui, MD, Silverio Perrotta, MD, Leyla Agaoglu, MD, Antonios Kattamis, MD, Patricia Giardina, MD, Gritta Janka-Schaub, MD, Herbert Opitz, PhD, Catherine Ressayre-Djaffer, PhD, Daniele Alberti, MD

Blood (2004) 104 (11): 3619.

https://doi.org/10.1182/blood.V104.11.3619.3619

Published: 2004

Journal Articles

Partial deletion in the JK locus causing a Jk null phenotype

Nicole Lucien, Jacques Chiaroni, Jean-Pierre Cartron, Pascal Bailly

Blood (2002) 99 (3): 1079–1081.

https://doi.org/10.1182/blood.V99.3.1079

Published: 2002

NARROW

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Epidemiological Data from the Algerian Multiple Myeloma Registry (AMMR) over 2 Years (June 2014-June 2016): Report of the Algerian Multiple Myeloma Study Group (GETMA)

Descriptive Study of Diffuse Large B Cell Lymphoma in Algeria and Tunisia over a Period of 5 Years

Depth of Response to ≥VGPR at Completion of Induction Influences Outcome Post ASCT, on Behalf of the Tunisian Myeloma Study Group

Epidemiological Approach of Chronic Myeloid Leukemia. Algerian-Tunisian Study

Safety of Subcutaneous Administration of Rituximab during the First-Line Treatment of Patients with Non-Hodgkin Lymphoma: The MabRella Study

Prospective, Multinational/Regional, Non-Interventional Study to Assess Treatment Practices in Anemia Patients Prone to Iron Overload: Results from the 3-Year Transfusional Hemosiderosis Registry (TORS)

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Chronic Myeloid Leukemia Patients In Tunisia: Epidemiology and Outcome In The Imatinib Era (A Multicentric Experience)

Hypercoagulability Linked to Breast Cancer Depends On the Stage and the Duration of the Tumor Evolution

Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience

Markers of Hypercoagulability in Breast Cancer: What Is Their Clinical Relevance?

Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

Human Platelet Alloantigens (HPA)1, HPA2 and HPA3 SNPs in Tunisian Sickle Cell Disease Patients

Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections.

Hodgkin Lymphoma (HL) in Tunisia Results of a 5 Year Prospective Multicenter Trial in 251 Pts

Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.

Partial deletion in the JK locus causing a Jk null phenotype

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only